rillr
About Guidelines Privacy Terms Log in Join Rillr
← Health
www.statnews.com · 5h

STAT+: FDA rejects Capricor Therapeutics’ Duchenne therapy, a decision that was a long time coming

The FDA said it had rejected a cell therapy intended for patients with Duchenne muscular dystrophy developed by Capricor Therapeutics.

Visit article ↗ ▲ 0 💬 0
Discussion

0 comments

No comments yet. Start the discussion.